Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...
المؤلفون الرئيسيون: | Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Elsevier
2019
|
مواد مشابهة
-
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
حسب: Donovan, JL, وآخرون
منشور في: (2017) -
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
حسب: J. Donovan, وآخرون
منشور في: (2003-01-01) -
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
حسب: Young, GJ, وآخرون
منشور في: (2017) -
Addressing patient treatment preferences at trial recruitment.
حسب: Mills, N, وآخرون
منشور في: (2011) -
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
حسب: Lane, A, وآخرون
منشور في: (2016)